FdaApplication
ANDA 210342
Identifiers
- fda_app_no: ANDA210342
Properties
| Property | Value |
|---|---|
| applicant_name | CHARTWELL MOLECULAR HOLDINGS LLC |
| application_type | ANDA |
| approval_date | 2020-01-03 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| BOSENTAN | BOSENTAN | 62.5MG | TABLET;ORAL |
| BOSENTAN | BOSENTAN | 125MG | TABLET;ORAL |
2 products